Engineering a humanized animal model of polycythemia vera with minimal <i>JAK2</i>V617F mutant allelic burden

類似資料

• Decrease in JAK2V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera
  著者:: Emil Kuriakose, 等
  出版事項: (2012-04-01)
• Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia
  著者:: Elisabetta Antonioli, 等
  出版事項: (2010-08-01)
• Sigmoid Venous Thrombosis in JAK2 V617F Mutated Polycythemia Vera
  著者:: Cilomar Martins De Oliveira Filho, 等
  出版事項: (2022-01-01)
• PB2192: JAK2 V617F ALLELE BURDEN AND THROMBOTIC EVENTS IN PATIENTS WITH JAK2 V617F POSITIVE POLYCYTHEMIA VERA OR ESSENTIAL THROMBOCYTHEMIA AT HIGH RISK OF THROMBOSIS
  著者:: Yun Hui Hwang, 等
  出版事項: (2023-08-01)
• Cerebral venous sinus thrombosis in polycythemia vera patients with JAK2V617F mutation
  著者:: Hui-Xin Shen, 等
  出版事項: (2021-05-01)